May 8, 2018 / 8:02 PM / 18 days ago

BRIEF-Enanta Pharmaceuticals Reports Q2 Earnings Per Share $0.61

May 8 (Reuters) - Enanta Pharmaceuticals Inc:

* ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL SECOND QUARTER ENDED MARCH 31, 2018

* Q2 EARNINGS PER SHARE $0.61

* Q2 EARNINGS PER SHARE VIEW $0.53 — THOMSON REUTERS I/B/E/S

* ROYALTY REVENUE FOR QUARTER INCREASED TO $44.0 MILLION DUE TO INCREASE IN ABBVIE’S MAVYRET SALES

* QTRLY TOTAL REVENUE WAS $44.0 MILLION, COMPARED TO $9.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below